| Literature DB >> 15725953 |
Spyros Kokolis1, Luther T Clark, Erdal Cavusoglu, Jonathan D Marmur.
Abstract
Direct thrombin inhibitors (DTI) are emerging as alternative anticoagulants to unfractionated heparin and indirect thrombin inhibitors in patients undergoing percutaneous coronary intervention (PCI). We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15725953 DOI： 10.1097/01.fjc.0000154373.80659.38
Source DB: PubMed Journal: J Cardiovasc Pharmacol ISSN： 0160-2446 Impact factor: 3.105